Clinical outcome in patients with cardiovascular diseases with COVID-19 in the second macro-region of Alagoas
DOI:
https://doi.org/10.26694/repis.v8i1.3070Keywords:
COVID-19, Physiology, Heart DiseasesAbstract
Introduction: Body's response to the COVID-19 virus leads to systemic inflammation, in which there is an increase in inflammatory markers and myocardial injury and/or cardiac dysfunction, predisposing the individual to acute heart failure, myocarditis, thrombosis and arrhythmias. Aim: to describe the main clinical outcomes of individuals with COVID-19 who reported cardiovascular problems. Outlining: this is a documentary study with quantitative approach. The research is based on the hospital censuses issued to the municipal health department of Arapiraca. The research has included the individuals infected with COVID-19 who self-reported preexistent cardiovascular diseases upon hospital admission, excluding the ones who developed cardiovascular diseases during hospitalization. Thus, the data analyzed were comprehended in the July to December 2020 period. The study was carried out between August and September 2021. After collecting the information, basic descriptive statistics were performed to systematize the data. Results: among the 260 self-reported cases of cardiovascular disorders, systemic arterial hypertension stands out for registering 85.38% of the cases. Next, cardiopathies exhibit 24.62% of occurrences. That said, it was possible to observe that the highest death rate was presented by heart diseases with 31.58% of the cases. On the other hand, it is noted that the highest rate of discharge occurrences was in patients with systemic arterial hypertension, with 55.40% of the target audience. Implications: the investigation made it possible to verify that discharge due to cure and death were the main clinical outcomes, respectively.
References
Ruff JMC. Comprehensive Review of Cardiovascular Involvement in COVID-19. Adv Crit Care [Internet]. 2021 Ago [cited 2022 Oct 8]; 32(2):169-87. Available form: https://doi.org/10.4037/aacnacc2021302
Silva-Ayarza I, Bachelet VC. What we know and don’t know on SARS-CoV-2 and COVID-19. Madewave [Internet]. 2021 Ago [cited 2022 Oct 8]; 21(4):1-12. Available form: https://doi.105867/medwave.2021.048198
Organização Pan-Americana da Saúde. Organização Mundial da Saúde. Alerta Epidemiológico Complicações e sequelas da COVID-19. Washington: PAHO/WHO; 2020. Available form: https://www.paho.org/bra/dmdocuments/covid-19-materiais-de-comunicacao-1/Alerta%20epidemiologico%20-%20Complicacoes%20e%20sequelas%20da%20COVID-19.pdf
Bielecka-Dabrowa A, Cichocka-Radwan A, Lewek J, Pawliczak F, Maciejewski M, Banach M. Cardiac manifestations of COVID-19. Rev cardiovasc med [Internet]. 2021 Ago [cited 2022 Oct 8]; 22(2):365-71. Available form: https://doi.org/10.31083/j.rcm2202043
Costa IBSS, Bittar CS, Rizk SI, Filho AEA, Santos KAQ, Machado TIV, et al. The Heart and COVID-19: What Cardiologists Need to Know. Arq. Bras. Cardiol [Internet]. 2020 Ago [cited 2022 Oct 8]; 114(5):805-816. Available form: https://doi.org/10.36660/abc.20200279
Ministério da Saúde (BR). Banco de dados do Sistema Único de Saúde - DATASUS: População residente - estimativas para o TCU - Alagoas. Brasília: Ministério da Saúde; 2019. Available form: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?ibge/cnv/poptal.def
Alagoas. Secretaria estadual de saúde. Plano Diretor de Regionalização [internet] 2011. Available form: http://cidadao.saude.al.gov.br/wp-content/uploads/2017/09/Plano-Diretor Regionalizacao-2011.pdf
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020 Ago [cited 2022 Oct 8]; 95(10223):497-506. Available form: https://doi.org/10.1016/S0140-6736(20)30183-5
Oliveira MC, Eleuterio TA, Corrêa ABA, Silva LDR, Rodrigues RC, Oliveira BA, et al. Factors associated with death in confirmed cases of COVID-19 in the state of Rio de Janeiro. BMC infect. dis [Internet]. 2021 Ago [cited 2022 Oct 8]; 21(687). Available form:
https://doi.org/10.1186/s12879-021-06384-1
Ministério da Saúde (BR). Estratégias para o cuidado da pessoa com doença crônica: hipertensão arterial sistêmica. Brasília: Ministério da Saúde; 2013. Available form: https://bvsms.saude.gov.br/bvs/publicacoes/estrategias_cuidado_pessoa_doenca_cronica.pdf
Sociedade Brasileira de Cardiologia (SBC). Portal Cardiol 2021. Available form: https://www.portal.cardiol.br/
Sanna G, Serrau G, Bassareo PP, Neroni P, Fanos V, Marcialis MA. Children's heart and COVID-19: Evidence updated in the form of a systematic review. Eur J Pediatr [Internet]. 2020 Ago [cited 2022 Oct 8]; 179:1079–1087. Available form: https://doi.org/10.1007/s00431-020 03699-0
Mascarello KC, Vieira ACBC, Souza ASS, Marcarini WD, Barauna VG, Maciel ELN. COVID-19 hospitalization and death and relationship with social determinants of health and morbidities in Espírito Santo State, Brazil: a cross-sectional study. Epidemiol Serv Saúde [Internet]. 2021 Ago [cited 2022 Oct 8]; 30(3):1-12. Available form: https://doi.org/10.1590/S1679 49742021000300004
Abayomi A, Osibogun A, Kanma-Okafor O, Idris J, Bowale A, Wright O, et al. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study. Glob health res polyci [Internet]. 2021 Ago [cited 2022 Oct 8]; 6(26):1-12. Available form: https://doi.org/10.1186/s41256-021-00210-6
Santos LG, Baggio JAO, Leal TC, Costa FA, Fernandes TRMO, Silva RV, et al. Prevalência de Hipertensão Arterial Sistêmica e Diabetes Mellitus em Indivíduos com COVID-19: Um Estudo Retrospectivo de Óbitos em Pernambuco, Brasil. Arq Bras Cardiol [Internet]. 2021 Ago [cited 2022 Oct 8]; 117(2). Available form: https://doi.org/10.36660/abc.20200885
